Hedge Fund News: Steven Cohen, John Burbank, BarclayHedge
SAC Re the Bermuda based Class 4 reinsurer backed by Steven A.
Posts Tagged ‘Jacob Gottlieb Visium Asset Management’
Is Teva Pharmaceutical Industries A Good Stock to Buy?
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)’s business has been doing well so far in 2012.
Orbimed Still Selling Pacira
Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter with exactly 2 million shares...
A Hedge Fund’s Bets in Generic Pharmaceuticals
Visium Asset Management was founded by Jacob Gottlieb in 2005.
Hedge Fund News: Pfizer, General Motors, Paul Tudor Jones
Pfizer (PFE) Inc., Johnson & Johnson (JNJ) and Elan Corp.
Hedge Fund Performance January 2012
HSBC published the Hedge Weekly for the week of Jan 30 to Feb 3, revealing a list of hedge funds’ performances in January 2012.
Hedge Fund Returns In 2011
HSBC published the Hedge Weekly #53, revealing a list of hedge funds’ return in 2011.
Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT).
D. E. Shaw Loses Big After InterMune Drops 18%
InterMune Inc. (ITMN) drops 18.64% at 2:05PM EST today.
Hedge Fund Performance In November
Hedge fund performance in November 2011 was more disappointing than any time since the bankruptcy of Lehman Brothers.
Seth Klarman’s Baupost Group Initiated New Passive Stake In Targacept Inc. (TRGT)
Seth Klarman’s Baupost Group disclosed on December 9th that the firm has initiated a 5.65 million shares brand new position in Targacept Inc.
Hedge Funds Make Big After $PLL Rises 8%
Pall Corporation (PLL) rose nearly 8% in trading on Friday after the company reported increases in revenue and adjusted earnings, which beat analyst expectations.
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th.
Hedge Funds Make a Bundle on Inhibitex $INHX
Shares of Inhibitex (INHX) more than doubled Friday morning.
Pivovarov Launches Altera Fund, Visium Hires Stockton, MF Global
A former Old Lane Partners manager has returned home to launch a high-concentrated hedge fund focused on Russia. Viatcheslav Pivovarov's Altera Capital will launch its maiden...
Hedge Funds Gain Big After Amlin $AMLN Reports Higher Than Expected
Amlin Pharmaceuticals (AMLN) rose 11.13% on Thursday morning after it reported a GAAP loss of 9 cents per share, which was narrower than the 15 cents per share loss estimated...
Top Hedge Funds in September
Hedge funds fell 3.2% in September according to Bloomberg, making September 2011 the worst month for hedge funds in over a year.
Visium Asset Management: Stock Picks and Performance
Visium Asset Management is founded by Jacob Gottlieb in 2005.
Hedge Fund Performance August 2011
Hedge fund performance in August 2011 was disappointing, according to Financial Times. "Hedge fund industry has failed to live up to its name" a recent article said.
25 Best Hedge Funds of Q2 2011
Insider Monkey tracks 300+ hedge funds and several other prominent investors. We believe investors can beat the index funds by imitating best hedge funds' stock picks.
Hedge Fund Winners in FDA Panel’s Regeneron Decision $REGN
A new eye medicine from Regeneron Pharmaceuticals (REGN) and Bayer AG was a safe and effective way of treating vision loss from macular degeneration, a U.S.
Samuel Isaly and OrbiMed Advisors Reduced Anthera Pharmaceuticals $ANTH
Samuel Isaly’s OrbiMed Advisors manages around $5 Billion in healthcare related equities and venture capital.
